Synaptic plasticity model of therapeutic sleep deprivation in major depression

详细信息    查看全文

• 作者：Elias Wolf^a ; Marion Kuhn^a ; Claus Normann^a ; Florian Mainberger^a ; Jonathan G. Maier^a ; Sarah Maywald^a ; Aliza Bredl^a ; Stefan Klö ; ppel^a ; Knut Biber^a ; Dietrich van Calker^a ; Dieter Riemann^a ; Annette Sterr^b ; Christoph Nissen^a ; ^{christoph.nissen@uniklinik-freiburg.de}
• 关键词：Major depressive disorder ; Therapeutic sleep deprivation ; LTP ; Synaptic plasticity ; Synaptic homeostasis
• 刊名：Sleep Medicine Reviews
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：30
• 期：Complete
• 页码：53-62
• 全文大小：583 K
• 卷排序：30

文摘

Therapeutic sleep deprivation (SD) is a rapid acting treatment for major depressive disorder (MDD). Within hours, SD leads to a dramatic decrease in depressive symptoms in 50–60% of patients with MDD. Scientifically, therapeutic SD presents a unique paradigm to study the neurobiology of MDD. Yet, up to now, the neurobiological basis of the antidepressant effect, which is most likely different from today's first-line treatments, is not sufficiently understood. This article puts the idea forward that sleep/wake-dependent shifts in synaptic plasticity, i.e., the neural basis of adaptive network function and behavior, represent a critical mechanism of therapeutic SD in MDD. Particularly, this article centers on two major hypotheses of MDD and sleep, the synaptic plasticity hypothesis of MDD and the synaptic homeostasis hypothesis of sleep-wake regulation, and on how they can be integrated into a novel synaptic plasticity model of therapeutic SD in MDD. As a major component, the model proposes that therapeutic SD, by homeostatically enhancing cortical synaptic strength, shifts the initially deficient inducibility of associative synaptic long-term potentiation (LTP) in patients with MDD in a more favorable window of associative plasticity. Research on the molecular effects of SD in animals and humans, including observations in the neurotrophic, adenosinergic, monoaminergic, and glutamatergic system, provides some support for the hypothesis of associative synaptic plasticity facilitation after therapeutic SD in MDD. The model proposes a novel framework for a mechanism of action of therapeutic SD that can be further tested in humans based on non-invasive indices and in animals based on direct studies of synaptic plasticity. Further determining the mechanisms of action of SD might contribute to the development of novel fast acting treatments for MDD, one of the major health problems worldwide.